Chemoinformaics analysis of Sulfoquinovosyl diglyceride
Molecular Weight | 841.158 | nRot | 35 |
Heavy Atom Molecular Weight | 764.55 | nRig | 15 |
Exact Molecular Weight | 840.506 | nRing | 1 |
Solubility: LogS | -2.112 | nHRing | 1 |
Solubility: LogP | 7.049 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 134 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 58 | No. of Aromatic Carbocycles | 0 |
nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 76 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 45 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
nHA | 11 | APOL | 138.35 |
nHD | 4 | BPOL | 91.5797 |
QED | 0.021 |
Synth | 5.028 |
Natural Product Likeliness | 1.057 |
NR-PPAR-gamma | 0.969 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.011 |
Pgp-sub | 0.343 |
HIA | 0.889 |
CACO-2 | -5.413 |
MDCK | 0.0000104 |
BBB | 0.002 |
PPB | 1.02957 |
VDSS | 0.575 |
FU | 0.0100007 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.043 |
CYP2c19-inh | 0.083 |
CYP2c19-sub | 0.038 |
CYP2c9-inh | 0.243 |
CYP2c9-sub | 0.998 |
CYP2d6-inh | 0.098 |
CYP2d6-sub | 0.034 |
CYP3a4-inh | 0.645 |
CYP3a4-sub | 0.012 |
CL | 1.594 |
T12 | 0.769 |
hERG | 0.524 |
Ames | 0.002 |
ROA | 0.001 |
SkinSen | 0.991 |
Carcinogencity | 0.142 |
EI | 0.064 |
Respiratory | 0.905 |
NR-Aromatase | 0.617 |
Antiviral | Yes |
Prediction | 0.693292 |